MedCity News July 10, 2024
A new partnership will give Hello Alpha patients access to Phenomix Sciences’ genetic obesity test.
Virtual primary care platform Hello Alpha has teamed up with Phenomix Sciences, a precision medicine biotechnology company, the companies announced Tuesday. The partnership will give Hello Alpha’s patients access to Phenomix Sciences’ genetic obesity test.
Palo Alto, California-based Hello Alpha primarily serves women and treats more than 100 medical conditions, including mental health, diabetes, weight loss, asthma and urinary tract infections. The company works with employers, or consumers can access its services directly. St. Paul, Minnesota-based Phenomix Sciences is focused on combating obesity through its MyPhenome test, a saliva test that identifies an individual’s phenotype, or an observable trait, of the disease.
Through the partnership,...
Today's Sponsors
Today's Sponsor